{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:07:44Z","timestamp":1790438864311,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.therap.2015.12.004","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T14:32:35Z","timestamp":1458311555000},"page":"355-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Les calcifications vasculaires sous anti-vitamines K\u00a0: un effet ind\u00e9sirable m\u00e9connu"],"prefix":"10.1016","volume":"71","author":[{"given":"Youssef","family":"Bennis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subashini","family":"Vengadessane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Bodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Bricca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2015.12.004_bib0270","series-title":"Les anticoagulants en France en 2014\u00a0: \u00e9tat des lieux, synth\u00e8se et surveillance","author":"ANSM","year":"2014"},{"issue":"19","key":"10.1016\/j.therap.2015.12.004_bib0275","doi-asserted-by":"crossref","first-page":"11210","DOI":"10.1016\/S0021-9258(18)33742-6","article-title":"Evidence that warfarin anticoagulant action involves two distinct reductase activities","volume":"257","author":"Fasco","year":"1982","journal-title":"J Biol Chem"},{"issue":"6\u00a0Suppl.","key":"10.1016\/j.therap.2015.12.004_bib0280","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"issue":"7241","key":"10.1016\/j.therap.2015.12.004_bib0285","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","article-title":"Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres","volume":"320","author":"Pouyanne","year":"2000","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.therap.2015.12.004_bib0290","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrcardio.2009.165","article-title":"Calcification in atherosclerosis","volume":"6","author":"Alexopoulos","year":"2009","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"10.1016\/j.therap.2015.12.004_bib0295","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.RES.0000249379.55535.21","article-title":"Vascular calcification: pathobiological mechanisms and clinical implications","volume":"99","author":"Johnson","year":"2006","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.therap.2015.12.004_bib0300","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2215\/CJN.01930408","article-title":"Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease","volume":"3","author":"McCullough","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.therap.2015.12.004_bib0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/HJH.0b013e328331b81e","article-title":"Pulse wave velocity and vascular calcification at different stages of chronic kidney disease","volume":"28","author":"Temmar","year":"2010","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.therap.2015.12.004_bib0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S4822","article-title":"Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis","volume":"5","author":"Rennenberg","year":"2009","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"10.1016\/j.therap.2015.12.004_bib0315","first-page":"271","article-title":"Pathophysiological mechanisms of vascular calcification","volume":"73","author":"H\u00e9naut","year":"2015","journal-title":"Ann Biol Clin (Paris)"},{"issue":"11","key":"10.1016\/j.therap.2015.12.004_bib0320","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneph.2013.176","article-title":"Mechanisms of vascular calcification in CKD-evidence for premature ageing?","volume":"9","author":"Shanahan","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.therap.2015.12.004_bib0325","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1525-139X.2002.00052.x","article-title":"Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment","volume":"15","author":"Wilmer","year":"2002","journal-title":"Semin Dial"},{"issue":"9","key":"10.1016\/j.therap.2015.12.004_bib0330","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrcardio.2010.115","article-title":"Regulatory mechanisms in vascular calcification","volume":"7","author":"Sage","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.therap.2015.12.004_bib0335","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/HYPERTENSIONAHA.109.134205","article-title":"Inflammation and the osteogenic regulation of vascular calcification: a review and perspective","volume":"55","author":"Shao","year":"2010","journal-title":"Hypertension"},{"issue":"6620","key":"10.1016\/j.therap.2015.12.004_bib0340","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature"},{"issue":"50","key":"10.1016\/j.therap.2015.12.004_bib0345","doi-asserted-by":"crossref","first-page":"31496","DOI":"10.1074\/jbc.272.50.31496","article-title":"Cloning and targeted deletion of the mouse fetuin gene","volume":"272","author":"Jahnen-Dechent","year":"1997","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.therap.2015.12.004_bib0350","first-page":"315","article-title":"Cardiovascular calcification inhibitors","volume":"73","author":"Liabeuf","year":"2015","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.therap.2015.12.004_bib0355","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0083-6729(08)60061-8","article-title":"Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function","volume":"42","author":"Price","year":"1985","journal-title":"Vitam Horm"},{"issue":"5","key":"10.1016\/j.therap.2015.12.004_bib0360","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.ATV.0000216406.44762.7c","article-title":"The elastic lamellae of devitalized arteries calcify when incubated in serum: evidence for a serum calcification factor","volume":"26","author":"Price","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"43","key":"10.1016\/j.therap.2015.12.004_bib0365","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1055\/s-0028-1110200","article-title":"A new autosomal-recessive hereditary syndrome. Multiple peripheral pulmonary stenosis, brachytelephalangia, inner-ear deafness, ossification or calcification of cartilages","volume":"96","author":"Keutel","year":"1971","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"10.1016\/j.therap.2015.12.004_bib0370","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/5102","article-title":"Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome","volume":"21","author":"Munroe","year":"1999","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.therap.2015.12.004_bib0375","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.a.30680","article-title":"A novel MGP mutation in a consanguineous family: review of the clinical and molecular characteristics of Keutel syndrome","volume":"135","author":"Hur","year":"2005","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.therap.2015.12.004_bib0380","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nephro.2014.12.003","article-title":"The matrix Gla protein awakening may lead to the demise of vascular calcification","volume":"11","author":"Delanaye","year":"2015","journal-title":"Nephrol Ther"},{"issue":"12","key":"10.1016\/j.therap.2015.12.004_bib0385","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1538-7836.2007.02758.x","article-title":"Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification","volume":"5","author":"Schurgers","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.therap.2015.12.004_bib0390","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1074\/jbc.M109683200","article-title":"Matrix Gla-protein, a regulatory protein for bone morphogenetic protein-2","volume":"277","author":"Zebboudj","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.therap.2015.12.004_bib0395","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jcb.10669","article-title":"Matrix Gla protein and BMP-2\u00a0regulate osteoinduction in calcifying vascular cells","volume":"90","author":"Zebboudj","year":"2003","journal-title":"J Cell Biochem"},{"issue":"9","key":"10.1016\/j.therap.2015.12.004_bib0400","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.ATV.18.9.1400","article-title":"Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves","volume":"18","author":"Price","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.therap.2015.12.004_bib0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2613.2000.00140.x","article-title":"Warfarin exposure and calcification of the arterial system in the rat","volume":"81","author":"Howe","year":"2000","journal-title":"Int J Exp Pathol"},{"issue":"2","key":"10.1016\/j.therap.2015.12.004_bib0410","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0895-7061(02)03204-1","article-title":"A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1\u00a0treatment","volume":"16","author":"Essalihi","year":"2003","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.therap.2015.12.004_bib0415","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.2013.530","article-title":"Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation","volume":"86","author":"Kaesler","year":"2014","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.therap.2015.12.004_bib0420","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1182\/blood-2006-07-035345","article-title":"Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats","volume":"109","author":"Schurgers","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.therap.2015.12.004_bib0425","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ki.2012.477","article-title":"Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease","volume":"83","author":"McCabe","year":"2013","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.therap.2015.12.004_bib0430","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1182\/blood-2004-04-1277","article-title":"Oral anticoagulant treatment: friend or foe in cardiovascular disease?","volume":"104","author":"Schurgers","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.therap.2015.12.004_bib0435","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjcard.2005.05.014","article-title":"Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography","volume":"96","author":"Koos","year":"2005","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.therap.2015.12.004_bib0440","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1538-7836.2009.03630.x","article-title":"Warfarin use and the risk of valvular calcification","volume":"7","author":"Lerner","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"20","key":"10.1016\/j.therap.2015.12.004_bib0445","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/eurheartj\/ehr226","article-title":"Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients","volume":"32","author":"Weijs","year":"2011","journal-title":"Eur J Heart"},{"issue":"8","key":"10.1016\/j.therap.2015.12.004_bib0450","doi-asserted-by":"crossref","first-page":"e43229","DOI":"10.1371\/journal.pone.0043229","article-title":"Vitamin K antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype","volume":"7","author":"Schurgers","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.therap.2015.12.004_bib0455","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/ATVBAHA.114.304392","article-title":"Increased vascular calcification in patients receiving warfarin","volume":"35","author":"Tantisattamo","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.therap.2015.12.004_bib0460","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00223-009-9300-4","article-title":"Does prolonged warfarin exposure potentiate coronary calcification in humans? Results of the warfarin and coronary calcification study","volume":"85","author":"Villines","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"10.1016\/j.therap.2015.12.004_bib0465","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MJT.0b013e318249a1c6","article-title":"Warfarin use and prevalence of coronary artery calcification assessed by multislice computed tomography","volume":"21","author":"Palaniswamy","year":"2014","journal-title":"Am J Ther"},{"issue":"20","key":"10.1016\/j.therap.2015.12.004_bib0470","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.therap.2015.12.004_bib0475","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nephro.2010.04.003","article-title":"Calciphylaxis in dialysis patients: to recognize and treat it as soon as possible","volume":"6","author":"Jean","year":"2010","journal-title":"Nephrol Ther"},{"issue":"5","key":"10.1016\/j.therap.2015.12.004_bib0480","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cursur.2004.12.016","article-title":"Calciphylaxis: rare but fatal","volume":"62","author":"Dosanjh","year":"2005","journal-title":"Curr Surg"},{"issue":"6","key":"10.1016\/j.therap.2015.12.004_bib0485","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.10-1322","article-title":"Warfarin-induced pulmonary metastatic calcification and calciphylaxis in a patient with end-stage renal disease","volume":"139","author":"Cadavid","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.therap.2015.12.004_bib0490","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000371449","article-title":"antagonists predispose to calciphylaxis in patients with end-stage renal disease","volume":"129","author":"Galloway","year":"2015","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.therap.2015.12.004_bib0495","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/gfr658","article-title":"A case-control study of calciphylaxis in Japanese end-stage renal disease patients","volume":"27","author":"Hayashi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.therap.2015.12.004_bib0500","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrneph.2010.143","article-title":"Atherosclerosis in CKD: differences from the general population","volume":"6","author":"Dr\u00fceke","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.therap.2015.12.004_bib0505","first-page":"417","article-title":"Warfarin and aortic valve calcification in hemodialysis patients","volume":"20","author":"Holden","year":"2007","journal-title":"J Nephrol"},{"issue":"2","key":"10.1016\/j.therap.2015.12.004_bib0510","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/15701611113119990146","article-title":"Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients","volume":"13","author":"Fusaro","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.therap.2015.12.004_bib0515","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2840-13-85","article-title":"Vascular calcification in patients with type 2\u00a0diabetes: the involvement of matrix Gla protein","volume":"13","author":"Liabeuf","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.therap.2015.12.004_bib0520","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1681\/ASN.2008080824","article-title":"Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients","volume":"20","author":"Chan","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.therap.2015.12.004_bib0525","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5414\/CN106481","article-title":"Warfarin use in hemodialysis patients: what is the risk?","volume":"75","author":"Phelan","year":"2011","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1016\/j.therap.2015.12.004_bib0265","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0034-1543999","article-title":"Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old?","volume":"41","author":"Tufano","year":"2015","journal-title":"Semin Thromb Hemost"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T13:42:17Z","timestamp":1655300537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0040595716000172"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2015.12.004","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les calcifications vasculaires sous anti-vitamines K\u00a0: un effet ind\u00e9sirable m\u00e9connu","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2015.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}